rs75076352
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(T;T) | 0 | common in clinvar |
Make rs75076352(G;G) |
Make rs75076352(G;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 10 |
Position | 43114500 |
Gene | RET |
is a | snp |
is | mentioned by |
dbSNP | rs75076352 |
dbSNP (classic) | rs75076352 |
ClinGen | rs75076352 |
ebi | rs75076352 |
HLI | rs75076352 |
Exac | rs75076352 |
Gnomad | rs75076352 |
Varsome | rs75076352 |
LitVar | rs75076352 |
Map | rs75076352 |
PheGenI | rs75076352 |
Biobank | rs75076352 |
1000 genomes | rs75076352 |
hgdp | rs75076352 |
ensembl | rs75076352 |
geneview | rs75076352 |
scholar | rs75076352 |
rs75076352 | |
pharmgkb | rs75076352 |
gwascentral | rs75076352 |
openSNP | rs75076352 |
23andMe | rs75076352 |
SNPshot | rs75076352 |
SNPdbe | rs75076352 |
MSV3d | rs75076352 |
GWAS Ctlg | rs75076352 |
Max Magnitude | 0 |
[PMID 3078962] Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
[PMID 7907913] Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.
[PMID 8825918] Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
[PMID 9111993] A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis.
[PMID 12000816] Germ-line mutations in nonsyndromic pheochromocytoma.
[PMID 2904651] Cushing's syndrome due to ectopic ACTH secretion by bilateral pheochromocytomas in multiple endocrine neoplasia type 2A.
[PMID 3078962] Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
[PMID 7849700] Haplotype analysis of MEN 2 mutations.
[PMID 7907913] Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.
[PMID 10522989] A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene.